Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

author
Fourdinier, Ophélie
Schepers, Eva
Metzinger-Le Meuth, Valérie
Liabeuf, Sophie
Vanholder, Raymond
Brigant, Benjamin
Pletinck, Anneleen
statement of authorship
Ophélie Fourdinier, Eva Schepers, Valérie Metzinger-Le Meuth, Griet Glorieux, Sophie Liabeuf, Francis Verbeke, Raymond Vanholder, Benjamin Brigant,Anneleen Pletinck, Momar Diouf, Stéphane Burtey, Gabriel Choukroun,Ziad A. Massy, Laurent Metzinger & on behalf of the European Uremic Toxin WorkGroup-EUTox
publisher
journal volume number month
vol. 9, 1
year of publication
pages
art. 447, 12 p. : ill
ISSN
2045-2322
notes
Bibliogr.: 65 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
category (general)
kvartiil
Q1
language
inglise
Fourdinier, O., Schepers, E., Metzinger-Le Meuth, V., Glorieux, G., Liabeuf, S., Verbeke, F., Vanholder, R., Brigant, B., Pletinck, A., Fridolin, I. et al. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients // Scientific reports (2019) vol. 9, 1, art. 447, 12 p. : ill. https://doi.org/10.1038/s41598-019-41101-8